News
News
VitaDX selected by Pfizer and WILCO to be part of the new #PfizerHealthcareHub France promo
16 janvier 2024 -
Avero Diagnostics and VitaDX announce the signing of a strategic partnership for the distribution in the United States of VisioCyt® Bladder, a diagnostic test for bladder cancer
18 décembre 2023 -
Launch of the participatory financing campaign!
14 novembre 2023 -
It's official: the Sowefund crowdfunding campaign is now public and open to all!…
VitaDX wins France2030's "Medical Imaging" call for projects!
18 octobre 2023 -
VisioCyt® on TF1!
8 juin 2023 -
A big thank you to the TF1 Group for this report broadcast on June 07, 2023 on the 8:00 pm news, showing the benefits of Artificial Intelligence…
Come and meet us !
2 janvier 2023 -
We will be present at several events in 2023. If you'd like to find out more about us and VisioCyt, our first innovative…
Mltidisciplinary Masterclass dedicated to prostate and bladder cancers
8 juillet 2022 -
Multidisciplinary Masterclass organized by the American Hospital in Paris, MEDIPATH and Ibex Medical Analytics dedicated to prostate and bladder…